Clinical Trial Update: Propiverine in Children Suffering From Non-Neurogenic Overactive Bladder and Urinary Incontinence [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of propiverine in children with non-neurogenic overactive bladder and urinary incontinence has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urinary Incontinence

Drugs mentioned

• Propiverine (propiverine)

Snippet

Sponsor: APOGEPHA Arzneimittel GmbH | Conditions: Overactive Bladder, Urinary Incontinence | Phase 3 | Status: COMPLETED